Article: Pharmaprojects reports on the explosive growth of the controlled-release market.

Richmond, UK, July 21 /PRNewswire/ -- Data published today by Pharmaprojects, the world's leading pharmaceutical R&D tracking database, shows an explosive trend in the number of drugs being developed as controlled release formulations. It is becoming generally acknowledged that controlled release formulations have the greatest revenue potential of any drugs enhanced by drug delivery technology.

"While controlled-release products used to be a drug delivery company speciality, nowadays big pharma has the capability to produce relatively simple controlled-release products by themselves. This is something they can't afford not to do!" said Nicole Yost, Editor of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!